Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kevin C.J. Nixon"'
Autor:
Benjamin H. Lok, Geoffrey Liu, Ming S. Tsao, Aaron D. Schimmer, Rod Bremner, Joel D. Pearson, Samir H. Barghout, Vijithan Sugumar, Ranya Barayan, Jessica Weiss, Lifang Song, Fariha Rahman, Vidhyasagar Venkatasubramanian, Kevin C.J. Nixon, Mansi K. Aparnathi, Safa Majeed
Supplementary Data from Targeting the Ubiquitin–Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07dec1598a9f1c977852b1ad0084664a
https://doi.org/10.1158/1078-0432.22483878.v1
https://doi.org/10.1158/1078-0432.22483878.v1
Autor:
Benjamin H. Lok, Geoffrey Liu, Ming S. Tsao, Aaron D. Schimmer, Rod Bremner, Joel D. Pearson, Samir H. Barghout, Vijithan Sugumar, Ranya Barayan, Jessica Weiss, Lifang Song, Fariha Rahman, Vidhyasagar Venkatasubramanian, Kevin C.J. Nixon, Mansi K. Aparnathi, Safa Majeed
Purpose:Small cell lung cancer (SCLC) is an aggressive disease with an overall 5-year survival rate of less than 10%. Treatment for SCLC with cisplatin/etoposide chemotherapy (C/E) ± radiotherapy has changed modestly over several decades. The ubiqui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62960533f4307a56243682fafcc1f621
https://doi.org/10.1158/1078-0432.c.6531261.v1
https://doi.org/10.1158/1078-0432.c.6531261.v1
Autor:
Safa Majeed, Mansi K. Aparnathi, Kevin C.J. Nixon, Vidhyasagar Venkatasubramanian, Fariha Rahman, Lifang Song, Jessica Weiss, Ranya Barayan, Vijithan Sugumar, Samir H. Barghout, Joel D. Pearson, Rod Bremner, Aaron D. Schimmer, Ming S. Tsao, Geoffrey Liu, Benjamin H. Lok
Publikováno v:
Clinical Cancer Research. 28:1966-1978
Purpose: Small cell lung cancer (SCLC) is an aggressive disease with an overall 5-year survival rate of less than 10%. Treatment for SCLC with cisplatin/etoposide chemotherapy (C/E) ± radiotherapy has changed modestly over several decades. The ubiqu
Autor:
Yang Yang, Jaeil Ahn, Nathan Edwards, Julius Benicky, Aaron M. Rozeboom, Bruce Davidson, Christina Karamboulas, Kevin C.J. Nixon, Laurie Ailles, Radoslav Goldman
SULF1 and SULF2 are oncogenic in a number of human malignancies, including head and neck squamous cell carcinoma (HNSC). The function of these two heparan sulfate editing enzymes was previously considered largely redundant but the biology of cancer s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f222f183aa6634f15c0dddfe1c3c440
https://doi.org/10.1101/2022.08.25.505356
https://doi.org/10.1101/2022.08.25.505356